Dr. Mark N. Stein
Claim this profileColumbia University Irving Medical Center
Expert in Prostate Cancer
Studies Cancer
18 reported clinical trials
33 drugs studied
Area of expertise
1Prostate Cancer
Global LeaderStage IV
MET positive
KIT positive
2Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Mark N. Stein is currently running
Immunotherapy
for Prostate Cancer
This is a multi-centre, Phase 1/2, open-label clinical trial of the VTP-850 prime-boost immunotherapeutic in men with biochemical recurrence after definitive local therapy for prostate cancer.
Recruiting1 award Phase 1 & 2
Surgery + Immunotherapy + Targeted Therapy
for Kidney Cancer
The purpose of this study is to determine if the use of immunotherapy nivolumab and the targeted therapy cabozantinib prior to removal of the kidney, will increase the number subjects who are without any visible kidney cancer in their body at some point during the course of treatment.
Recruiting1 award Phase 210 criteria
More about Mark N. Stein
Clinical Trial Related1 year of experience running clinical trials · Led 18 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Mark N. Stein has experience with
- Nivolumab
- Cabozantinib
- HB-302/HB-301 Alternating 2-Vector Therapy
- Atezolizumab
- Abiraterone
- Enzalutamide
Breakdown of trials Mark N. Stein has run
Prostate Cancer
Cancer
Tumors
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark N. Stein specialize in?
Mark N. Stein focuses on Prostate Cancer and Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are MET positive.
Is Mark N. Stein currently recruiting for clinical trials?
Yes, Mark N. Stein is currently recruiting for 9 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Mark N. Stein has studied deeply?
Yes, Mark N. Stein has studied treatments such as Nivolumab, Cabozantinib, HB-302/HB-301 Alternating 2-Vector Therapy.
What is the best way to schedule an appointment with Mark N. Stein?
Apply for one of the trials that Mark N. Stein is conducting.
What is the office address of Mark N. Stein?
The office of Mark N. Stein is located at: Columbia University Irving Medical Center, New York, New York 10032 United States. This is the address for their practice at the Columbia University Irving Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.